427 related articles for article (PubMed ID: 15604247)
1. Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice.
Sieber OM; Howarth KM; Thirlwell C; Rowan A; Mandir N; Goodlad RA; Gilkar A; Spencer-Dene B; Stamp G; Johnson V; Silver A; Yang H; Miller JH; Ilyas M; Tomlinson IP
Cancer Res; 2004 Dec; 64(24):8876-81. PubMed ID: 15604247
[TBL] [Abstract][Full Text] [Related]
2. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
[TBL] [Abstract][Full Text] [Related]
3. Hyperplastic polyps and sessile serrated adenomas as a phenotypic expression of MYH-associated polyposis.
Boparai KS; Dekker E; Van Eeden S; Polak MM; Bartelsman JF; Mathus-Vliegen EM; Keller JJ; van Noesel CJ
Gastroenterology; 2008 Dec; 135(6):2014-8. PubMed ID: 19013464
[TBL] [Abstract][Full Text] [Related]
4. MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis.
Reitmair AH; Cai JC; Bjerknes M; Redston M; Cheng H; Pind MT; Hay K; Mitri A; Bapat BV; Mak TW; Gallinger S
Cancer Res; 1996 Jul; 56(13):2922-6. PubMed ID: 8674041
[TBL] [Abstract][Full Text] [Related]
5. Interaction between murine germline mutations in p53 and APC predisposes to pancreatic neoplasia but not to increased intestinal malignancy.
Clarke AR; Cummings MC; Harrison DJ
Oncogene; 1995 Nov; 11(9):1913-20. PubMed ID: 7478622
[TBL] [Abstract][Full Text] [Related]
6. Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity.
Li P; Schulz S; Bombonati A; Palazzo JP; Hyslop TM; Xu Y; Baran AA; Siracusa LD; Pitari GM; Waldman SA
Gastroenterology; 2007 Aug; 133(2):599-607. PubMed ID: 17681179
[TBL] [Abstract][Full Text] [Related]
7. MUTYH-null mice are susceptible to spontaneous and oxidative stress induced intestinal tumorigenesis.
Sakamoto K; Tominaga Y; Yamauchi K; Nakatsu Y; Sakumi K; Yoshiyama K; Egashira A; Kura S; Yao T; Tsuneyoshi M; Maki H; Nakabeppu Y; Tsuzuki T
Cancer Res; 2007 Jul; 67(14):6599-604. PubMed ID: 17638869
[TBL] [Abstract][Full Text] [Related]
8. Novel findings in Swedish patients with MYH-associated polyposis: mutation detection and clinical characterization.
Kanter-Smoler G; Björk J; Fritzell K; Engwall Y; Hallberg B; Karlsson G; Grönberg H; Karlsson P; Wallgren A; Wahlström J; Hultcrantz R; Nordling M
Clin Gastroenterol Hepatol; 2006 Apr; 4(4):499-506. PubMed ID: 16616356
[TBL] [Abstract][Full Text] [Related]
9. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis.
Li Q; Ishikawa TO; Oshima M; Taketo MM
Cancer Res; 2005 Oct; 65(19):8622-7. PubMed ID: 16204028
[TBL] [Abstract][Full Text] [Related]
10. Role of nucleotide excision repair deficiency in intestinal tumorigenesis in multiple intestinal neoplasia (Min) mice.
Steffensen IL; Schut HA; Nesland JM; Tanaka K; Alexander J
Mutat Res; 2006 Dec; 611(1-2):71-82. PubMed ID: 16962818
[TBL] [Abstract][Full Text] [Related]
11. Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumors.
Al-Tassan N; Chmiel NH; Maynard J; Fleming N; Livingston AL; Williams GT; Hodges AK; Davies DR; David SS; Sampson JR; Cheadle JP
Nat Genet; 2002 Feb; 30(2):227-32. PubMed ID: 11818965
[TBL] [Abstract][Full Text] [Related]
12. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH.
Sieber OM; Lipton L; Crabtree M; Heinimann K; Fidalgo P; Phillips RK; Bisgaard ML; Orntoft TF; Aaltonen LA; Hodgson SV; Thomas HJ; Tomlinson IP
N Engl J Med; 2003 Feb; 348(9):791-9. PubMed ID: 12606733
[TBL] [Abstract][Full Text] [Related]
13. Loss of Apc+ in intestinal adenomas from Min mice.
Luongo C; Moser AR; Gledhill S; Dove WF
Cancer Res; 1994 Nov; 54(22):5947-52. PubMed ID: 7954427
[TBL] [Abstract][Full Text] [Related]
14. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis.
Zeilstra J; Joosten SP; Dokter M; Verwiel E; Spaargaren M; Pals ST
Cancer Res; 2008 May; 68(10):3655-61. PubMed ID: 18483247
[TBL] [Abstract][Full Text] [Related]
15. Effects of dietary folate on intestinal tumorigenesis in the apcMin mouse.
Song J; Medline A; Mason JB; Gallinger S; Kim YI
Cancer Res; 2000 Oct; 60(19):5434-40. PubMed ID: 11034085
[TBL] [Abstract][Full Text] [Related]
16. Loss of functional Fas ligand enhances intestinal tumorigenesis in the Min mouse model.
Fingleton B; Carter KJ; Matrisian LM
Cancer Res; 2007 May; 67(10):4800-6. PubMed ID: 17510409
[TBL] [Abstract][Full Text] [Related]
17. Germline mutations but not somatic changes at the MYH locus contribute to the pathogenesis of unselected colorectal cancers.
Halford SE; Rowan AJ; Lipton L; Sieber OM; Pack K; Thomas HJ; Hodgson SV; Bodmer WF; Tomlinson IP
Am J Pathol; 2003 May; 162(5):1545-8. PubMed ID: 12707038
[TBL] [Abstract][Full Text] [Related]
18. Opposite effects of modifiers of the ApcMin mutation in intestine and mammary gland.
Czarnomska A; Krysiak E; Piskorowska J; Sitarz M; Pysniak K; Pilcík T; Demant P
Cancer Res; 2003 Aug; 63(15):4533-7. PubMed ID: 12907628
[TBL] [Abstract][Full Text] [Related]
19. Chemopreventive effects of dietary folate on intestinal polyps in Apc+/-Msh2-/- mice.
Song J; Sohn KJ; Medline A; Ash C; Gallinger S; Kim YI
Cancer Res; 2000 Jun; 60(12):3191-9. PubMed ID: 10866310
[TBL] [Abstract][Full Text] [Related]
20. Germline MYH mutations in a clinic-based series of Canadian multiple colorectal adenoma patients.
Croitoru ME; Cleary SP; Berk T; Di Nicola N; Kopolovic I; Bapat B; Gallinger S
J Surg Oncol; 2007 May; 95(6):499-506. PubMed ID: 17219385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
